Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-06-18
1987-04-28
Rosen, Sam
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514313, 546152, 546153, 546155, 546156, 546159, A61K 3147, C07D21514
Patent
active
046614990
ABSTRACT:
Compounds having the formula: ##STR1## are selective antagonists of leukotrienes of D.sub.4 and inhibitors of the syntheses of LTA.sub.4, B.sub.4, C.sub.4, D.sub.4, E.sub.4, and F.sub.4. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory agents, and cytoprotective agents.
REFERENCES:
patent: 2727387 (1977-12-01), DEX
patent: 4236912 (1980-12-01), Johnston
patent: 4408076 (1983-10-01), Lee
patent: 4444584 (1984-04-01), Serban
J. Chem. Soc. Dalton 1259, 1264 (1980), Antony Deeming et al.
Org. Reactions, VII, R. Adams, ed., p. 82, (1953).
Aldrich Fine Chemicals, 58, 145 (1986).
Reagents for Org. Syn., 4, Fieser & Fieser, 448-449 (1974).
Young Robert N.
Zamboni Robert
Benson Robert
Lopez Gabriel
Merck Frosst Canada Inc.
Pfeiffer Hesna J.
Rosen Sam
LandOfFree
2-[(substituted)-phenoxymethyl]quinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-[(substituted)-phenoxymethyl]quinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-[(substituted)-phenoxymethyl]quinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-477533